{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:43:28Z","timestamp":1790520208648,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31230047"],"award-info":[{"award-number":["31230047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81521002"],"award-info":[{"award-number":["81521002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571386"],"award-info":[{"award-number":["81571386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National Key Technology R&D Program","award":["2015BAI13B06"],"award-info":[{"award-number":["2015BAI13B06"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ygyno.2017.08.010","type":"journal-article","created":{"date-parts":[[2017,8,26]],"date-time":"2017-08-26T19:00:28Z","timestamp":1503774028000},"page":"408-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["TET1 inhibits EMT of ovarian cancer cells through activating Wnt\/\u03b2-catenin signaling inhibitors DKK1 and SFRP2"],"prefix":"10.1016","volume":"147","author":[{"given":"Hongying","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.08.010_bb0005","series-title":"Advances in Ovarian Cancer Management","first-page":"6","article-title":"Etiology and overview","author":"Ye","year":"2012"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Bell","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/IGC.0b013e31821caa6f","article-title":"Wnt and hedgehog gene pathway expression in serous ovarian cancer","volume":"21","author":"Schmid","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bjc.6602719","article-title":"The Notch pathway in ovarian carcinomas and adenomas","volume":"93","author":"Hopfer","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0025","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1078-0432.CCR-13-1256","article-title":"A collagen-remodeling gene signature regulated by TGF-\u03b2 signaling is associated with metastasis and poor survival in serous ovarian cancer","volume":"20","author":"Cheon","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0030","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1158\/1078-0432.CCR-08-1414","article-title":"Role of hedgehog signaling in ovarian cancer","volume":"14","author":"Bhattacharya","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0035","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00404-014-3377-3","article-title":"PI3K\/AKT\/mTOR signaling pathway as a therapeutic target for ovarian cancer","volume":"290","author":"Li","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0040","doi-asserted-by":"crossref","first-page":"re8","DOI":"10.1126\/scisignal.2005189","article-title":"Signaling mechanisms of the epithelial-mesenchymal transition","volume":"7","author":"Gonzalez","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0045","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","article-title":"The Wnt\/beta-catenin pathway in ovarian cancer: a review","volume":"131","author":"Arend","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031885","article-title":"Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients","volume":"7","author":"Jacob","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.med.59.061606.095816","article-title":"Cancer epigenetics: modifications, screening, and therapy","volume":"59","author":"Galyam","year":"2008","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymeth.2010.04.009","article-title":"Whole genome DNA methylation analysis based on high throughput sequencing technology","volume":"52","author":"Li","year":"2010","journal-title":"Methods"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nmeth.1828","article-title":"DNA methylome analysis using short bisulfite sequencing data","volume":"9","author":"Krueger","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tibs.2005.12.008","article-title":"Genomic DNA methylation: the mark and its mediators","volume":"31","author":"Klose","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002750","article-title":"In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases","volume":"8","author":"Arand","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0085","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature12750","article-title":"TET enzymes, TDG and the dynamics of DNA demethylation","volume":"502","author":"Kohli","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13073-015-0134-6","article-title":"TET proteins and the control of cytosine demethylation in cancer","volume":"7","author":"Scourzic","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0095","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7150\/jca.12010","article-title":"Genetic characterization of ten-eleven-translocation methylcytosine dioxygenase alterations in human glioma","volume":"6","author":"Kraus","year":"2015","journal-title":"J. Cancer"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0100","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00432-014-1901-2","article-title":"Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer","volume":"141","author":"Rawluszkowieczorek","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0105","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nprot.2010.190","article-title":"Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling","volume":"6","author":"Gu","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1158\/1535-7163.MCT-05-0408","article-title":"Prediction of individual response to platinum\/paclitaxel combination using novel marker genes in ovarian cancers","volume":"5","author":"Komatsu","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mrrev.2011.05.002","article-title":"Initial steps of metastasis: cell invasion and endothelial transmigration","volume":"728","author":"Van Zijl","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0125","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.bjc.6602988","article-title":"Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours","volume":"94","author":"Wang","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0090-8258(02)00015-X","article-title":"Beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma","volume":"88","author":"Lee","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0135","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ejca.2005.01.022","article-title":"Beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients","volume":"41","author":"Kildal","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0140","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1038\/sj.onc.1210054","article-title":"Function and biological roles of the Dickkopf family of Wnt modulators","volume":"25","author":"Niehrs","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0145","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1038\/sj.onc.1203783","article-title":"Secreted frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells","volume":"19","author":"Roth","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/hmg\/10.7.687","article-title":"Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer","volume":"10","author":"Baylin","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0155","first-page":"7641","article-title":"DNA methylation in serum of breast cancer patients: an independent prognostic marker","volume":"63","author":"Muller","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0160","doi-asserted-by":"crossref","first-page":"10219","DOI":"10.1007\/s13277-016-4893-5","article-title":"DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC)","volume":"37","author":"Evelonn","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017676","article-title":"Changes in gene expression and cellular architecture in an ovarian cancer progression model","volume":"6","author":"Creekmore","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0170","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1101\/gad.225334.113","article-title":"Epithelial-mesenchymal plasticity in carcinoma metastasis","volume":"27","author":"Tsai","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","article-title":"Epithelial-mesenchymal transition in ovarian cancer","volume":"291","author":"Vergara","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2017.08.010_bb0180","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.18632\/oncotarget.2957","article-title":"FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells","volume":"6","author":"Chiu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0185","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1038\/onc.2010.309","article-title":"MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells","volume":"29","author":"Ponnusamy","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0190","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0195","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.25083","article-title":"Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway","volume":"127","author":"Su","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.08.010_bb0200","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1038\/sj.onc.1209439","article-title":"Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer","volume":"25","author":"Aguilera","year":"2006","journal-title":"Oncogene"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817312489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817312489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T04:32:13Z","timestamp":1535430733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817312489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0090825817312489"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.08.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TET1 inhibits EMT of ovarian cancer cells through activating Wnt\/\u03b2-catenin signaling inhibitors DKK1 and SFRP2","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}